NZ and the MRNA | 18 Nov 2023
The document below is the Post Marketing Safety Surveillance for the first 90 days of use of the #pfizer covid vaccine globally
The NZ roll out of this product started in February 2021
A few weeks after the onset of NZ rollout Medsafe will have been in possession of this document.
In the first 90 days of use Pfizer received the following CARDIAC injury reports
The median time between receipt of the injection and the onset of CARDIAC injury was 24 hours.
This is a very strongly temporal connection and highly indicative of a CAUSAL effect 1441 Cardiac injury reports
Myocardial infarction (89),
Cardiac failure (80),
Acute myocardial infarction (41),
Cardiac failure acute (11),
Cardiogenic shock and Postural orthostatic tachycardia syndrome (7 each)
Coronary artery disease (6);